Industries BiotechnologyGeneticsHealth CareMedicalPharmaceuticalHeadquarters Regions Greater Boston Area, East Coast, New England Founded Date 2010 Founders Derrick Rossi, Kenneth Chien, Noubar Afeyan, Stephane Bancel, Timothy A. Springer Operating Status Active Last Funding Type Post-IPO Equity Also Known As Moderna Legal Name Moderna, Inc. Hub Tags Exited Unicorn
Stock Symbol NASDAQ:MRNA Company Type For Profit
Investor Type Investment Bank Investment Stage Seed Number of Exits
Contact Email info@modernatx.com Phone Number 617-714-6500
Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies inside
patient cells.
Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology.
Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.